Harte Hanks (HHS) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
14 Aug, 2026Executive summary
Entered into a merger agreement with Star Equity Holdings, Inc. on August 14, 2026, with closing expected in Q4 2026. Shareholders will receive either $5.00 per share in cash or preferred stock, subject to a 50% cash cap.
Revenue for Q2 2026 was $38.0M, down 1.7% year-over-year; net loss widened to $5.0M from $0.3M in Q2 2025.
Operating expenses increased 10% year-over-year, driven by higher professional service and legal costs related to the pending acquisition.
Financial highlights
Q2 2026 revenue: $38.0M (-1.7% YoY); six-month revenue: $75.2M (-6.2% YoY).
Q2 2026 net loss: $5.0M (vs. $0.3M loss in Q2 2025); six-month net loss: $5.6M (vs. $0.7M loss in 2025).
Basic and diluted EPS: $(0.67) for Q2 2026, $(0.76) for six months.
Cash and equivalents at June 30, 2026: $5.2M; $3.0M drawn on credit facility.
Outlook and guidance
Management believes liquidity is sufficient for ongoing operations and obligations.
No dividends paid; $4.1M remains authorized for share repurchases.
No explicit forward guidance provided due to pending merger.
Latest events from Harte Hanks
- All director nominees, Say on Pay, and auditor ratification proposals were approved by majority vote.HHS
AGM 2026 - Revenue fell 10.3% and net loss widened, but strong liquidity supports a positive outlook.HHS
Q1 2026 - Operational improvements, governance enhancements, and key votes position the company for growth.HHS
Proxy filing - Positive EBITDA and improved net results in FY 2025 despite lower revenue and segment declines.HHS
Q4 2025 - Shareholders to vote on board, executive pay, and auditor as company targets growth and innovation.HHS
Proxy Filing - Beneficial ownership update adds Rosenbachs as 26.26% holders for 2025 meeting.HHS
Proxy Filing - Q3 2025 revenue dropped 17% with net loss, but cost controls and new deals support outlook.HHS
Q3 2025 - Q3 revenue up 1.1% YoY; profit metrics declined; Q4 revenue expected to contract.HHS
Q3 2024 - Q2 net loss of $27.8M from pension charge; Sales Services surged, cash strong, no debt.HHS
Q2 2024